Protekt Therapeutics

About:

Protekt Therapeutics is a drug development company aiming to develop inhibitors of PKR for various diseases

Top Investors: Fonds de solidarité FTQ, OrbiMed, Johnson & Johnson Innovation – JJDC, Bukwang Pharmaceutical Co, Takeda Ventures

Description:

ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.

Total Funding Amount:

$4.1M

Headquarters Location:

Ness Ziona, HaMerkaz, Israel

Founded Date:

2015-12-01

Contact Email:

info(AT)protektx.com

Founders:

Yotam Nisemblat

Number of Employees:

1-10

Last Funding Date:

2019-11-12

IPO Status:

Private

Industries: